These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12724111)

  • 1. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.
    Kimura M; Tateno A; Robinson RG
    Am J Geriatr Psychiatry; 2003; 11(3):320-7. PubMed ID: 12724111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial.
    Kimura M; Robinson RG; Kosier JT
    Stroke; 2000 Jul; 31(7):1482-6. PubMed ID: 10884441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study.
    Chemerinski E; Robinson RG; Arndt S; Kosier JT
    J Nerv Ment Dis; 2001 Jul; 189(7):421-5. PubMed ID: 11504318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K; Kosier JT; Robinson RG
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression.
    Chan KL; Campayo A; Moser DJ; Arndt S; Robinson RG
    Arch Phys Med Rehabil; 2006 Jun; 87(6):793-8. PubMed ID: 16731214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speed of improvement in sleep disturbance and anxiety compared with core mood symptoms during acute treatment of depression in old age.
    Dombrovski AY; Blakesley-Ball RE; Mulsant BH; Mazumdar S; Houck PR; Szanto K; Reynolds CF
    Am J Geriatr Psychiatry; 2006 Jun; 14(6):550-4. PubMed ID: 16731725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine in major depression with comorbid generalized anxiety disorder.
    Goodnick PJ; Puig A; DeVane CL; Freund BV
    J Clin Psychiatry; 1999 Jul; 60(7):446-8. PubMed ID: 10453798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief.
    Zygmont M; Prigerson HG; Houck PR; Miller MD; Shear MK; Jacobs S; Reynolds CF
    J Clin Psychiatry; 1998 May; 59(5):241-5. PubMed ID: 9632035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
    Kok RM; Nolen WA; Heeren TJ
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is poststroke depression a major depression?
    da Rocha e Silva CE; Alves Brasil MA; Matos do Nascimento E; de Bragança Pereira B; André C
    Cerebrovasc Dis; 2013; 35(4):385-91. PubMed ID: 23635428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
    Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
    J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative Antidepressant Effect of Chamomile (
    Amsterdam JD; Li QS; Xie SX; Mao JJ
    J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
    Fiedorowicz JG; Takezawa K; Robinson RG
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.